Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
Clinical trial NCT05225363 · RECRUITING
Trial details
- NCT number
- NCT05225363
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2028-11-05
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.